首页 > 抗体蛋白 > 抗体
APC anti-mouse NK-1.1 Antibody
产品名称:
APC anti-mouse NK-1.1 Antibody
产品类别:
抗体
产品编号:
108709
产品应用:
108709
[价格]
规格 价格 库存
25µg ¥ 1232 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The NK-1.1 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 108712).

Application References

(PubMed link indicates BioLegend citation)
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  17. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  2. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  3. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  4. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  5. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  6. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  7. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  8. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  9. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  10. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  11. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  12. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  13. Shen T, et al. 2019. Cell Death Discov. 5:123. PubMed
  14. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  15. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  16. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  17. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  18. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  19. Sun SJ, et al. 2022. Commun Biol. 5:867. PubMed
  20. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  21. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  22. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  23. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  24. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  25. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  26. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  27. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  28. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  29. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  30. Janakiram N, et al. 2016. Sci Rep. 6:37046. PubMed
  31. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  32. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  33. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  34. Hirata Y, et al. 2015. PLoS One. 10: 0141785. PubMed
  35. Wei SC, et al. 2020. Cancer Discov. . PubMed
  36. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  37. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  38. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  39. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  40. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  41. Hernández–Santos N, et al. 2018. Cell Host Microbe. 1.313194444. PubMed
  42. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  43. Guo L, et al. 2021. Front Immunol. 12:785457. PubMed
  44. Zenker S, et al. 2014. J Immunol. 192:2830. PubMed
  45. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  46. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  47. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  48. Hutter K, et al. 2020. FEBS J. . PubMed
  49. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  50. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  51. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  52. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  53. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  54. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  55. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  56. Kim S, et al. 2021. Elife. 10:. PubMed
  57. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  58. Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed
  59. Solaymani-Mohammadi S, et al. 2016. J Leukoc Biol. 99: 475 - 482. PubMed
  60. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  61. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  62. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  63. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  64. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  65. Terhorst D, et al. 2015. J Immunol. 195: 4953 - 4961. PubMed
  66. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  67. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  68. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  69. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  70. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  71. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  72. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  73. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  74. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  75. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  76. Zhang H, et al. 2017. Immunol Cell Biol. 10.1038/icb.2017.11. PubMed
  77. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  78. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  79. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  80. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  81. Huang W, et al. 2014. J Leukoc Biol. 96:55. PubMed
  82. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  83. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  84. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  85. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  86. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  87. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  88. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  89. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  90. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  91. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  92. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  93. Liu CF, et al. 2017. Front Immunol. 1.445833333. PubMed
  94. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  95. Gawish R, et al. 2022. Elife. 11:. PubMed
  96. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  97. Schmidts A, et al. 2020. J Immunother Cancer. 8:. PubMed
  98. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
RRID
AB_313396 (BioLegend Cat. No. 108709) AB_313397 (BioLegend Cat. No. 108710)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线